---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-018011"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:18:13.504739+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Vascular Q2 sales $42.1M (+8% organic); raises FY guidance to 10% organic growth

## Summary
- Q2 2022 sales $42.1M (+4%, +8% organic); reported EPS $0.16 (-60%); adjusted EPS ex-special charge $0.29 (-26%).
- Operating income $5.8M (-48%); ex-$3.1M special charge from closing St. Etienne factory, op income $8.9M (-20%).
- FY 2022 guidance raised: sales $162.7M-$165.3M (mid $164M, +10% organic); op income ex-special $32.7M-$34.4M.
- Board declared $0.125 quarterly dividend, payable Sept 8 to holders of record Aug 25; $20M share repurchase program ongoing.
- Operational milestones: Seoul office opened, French factory closed, Chinese XenoSure cardiac approval filed, Omniflow II CE Mark received.

## SEC filing metadata
- accession: 0001437749-22-018011
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774922018011/0001437749-22-018011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774922018011/lmat20220728_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-018011
- JSON: https://secwatch.observer/filing/0001437749-22-018011.json
- Plain text: https://secwatch.observer/filing/0001437749-22-018011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.